Jianai Ji

1.3k total citations · 1 hit paper
8 papers, 1.1k citations indexed

About

Jianai Ji is a scholar working on Molecular Biology, Oncology and Sociology and Political Science. According to data from OpenAlex, Jianai Ji has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Sociology and Political Science. Recurrent topics in Jianai Ji's work include Genomics, phytochemicals, and oxidative stress (4 papers), Glutathione Transferases and Polymorphisms (3 papers) and Protein Degradation and Inhibitors (3 papers). Jianai Ji is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), Glutathione Transferases and Polymorphisms (3 papers) and Protein Degradation and Inhibitors (3 papers). Jianai Ji collaborates with scholars based in China. Jianai Ji's co-authors include Zhengyu Jiang, Qidong You, Mengchen Lu, Yijun Liu, Tian Liu, Zhenwei Yuan, Zhiyun Chen, Yuxuan Zhu, Xiaoli Xu and Shicheng Xu and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Jianai Ji

8 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update

2016 648 citations Mengchen Lu, Jianai Ji et al. Medicinal Research Reviews profile →

Peers

Countries citing papers authored by Jianai Ji

Since Specialization

Citations

This map shows the geographic impact of Jianai Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianai Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianai Ji more than expected).

Fields of papers citing papers by Jianai Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianai Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianai Ji. The network helps show where Jianai Ji may publish in the future.

Co-authorship network of co-authors of Jianai Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Jianai Ji. A scholar is included among the top collaborators of Jianai Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianai Ji. Jianai Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Discovery of a NCOA4 Degrader for Labile Iron-Dependent Ferroptosis Inhibition 2024 ·Journal of Medicinal Chemistry ·Jianai Ji, Yuhui Jin, (unknown), Yuxuan Zhu, (unknown), Qidong You, Zhengyu Jiang	6
2	Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response 2023 ·Cell chemical biology ·Mengchen Lu, Jianai Ji, Yifei Lv, J. Zhao, Yuting Liu, (unknown), Tian Liu, Yi Mou, Qidong You, Zhengyu Jiang	9
3	ARE-PROTACs Enable Co-degradation of an Nrf2–MafG Heterodimer 2023 ·Journal of Medicinal Chemistry ·Jianai Ji, (unknown), Yuxuan Zhu, (unknown), (unknown), Qidong You, Zhengyu Jiang	22
4	Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope 2022 ·Acta Pharmaceutica Sinica B ·(unknown), Jianai Ji, (unknown), Yuxuan Zhu, (unknown), Xian Zhang, Shicheng Xu, Tianbao Zhu, Xiaoli Xu, Qidong You, Zhengyu Jiang	27
5	Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway 2018 ·European Journal of Medicinal Chemistry ·Mengchen Lu, Tian Liu, (unknown), Jianai Ji, (unknown), Yijun Liu, Qidong You, Zhengyu Jiang	228
6	An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis 2016 ·Scientific Reports ·Mengchen Lu, Jianai Ji, (unknown), Zhiyun Chen, Zhenwei Yuan, Qidong You, Zhengyu Jiang	104
7	The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update breakdown → 2016 ·Medicinal Research Reviews ·Mengchen Lu, Jianai Ji, Zhengyu Jiang, Qidong You	648
8	Polar Recognition Group Study of Keap1-Nrf2 Protein–Protein Interaction Inhibitors 2016 ·ACS Medicinal Chemistry Letters ·Mengchen Lu, (unknown), Jianai Ji, Zhiyun Chen, Zhenwei Yuan, Qidong You, Zhengyu Jiang	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact